Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans.

MLA

Zhou, Katherine I., et al. “Real-World Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans.” JCO Precision Oncology, vol. 7, Mar. 2023, p. e2200692. EBSCOhost, https://doi.org/10.1200/PO.22.00692.

APA

Zhou, K. I., Vashistha, V., Guo, A., Ahmed, S., & Kelley, M. J. (2023). Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans. JCO Precision Oncology, 7, e2200692. https://doi.org/10.1200/PO.22.00692

Chicago

Zhou, Katherine I, Vishal Vashistha, Aixia Guo, Sara Ahmed, and Michael J Kelley. 2023. “Real-World Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans.” JCO Precision Oncology 7 (March): e2200692. doi:10.1200/PO.22.00692.